{"id":63031,"date":"2026-04-30T13:02:35","date_gmt":"2026-04-30T11:02:35","guid":{"rendered":"https:\/\/pharma-trend.com\/en\/bristol-myers-squibb-reports-first-quarter-financial-results-for-2026\/"},"modified":"2026-04-30T13:02:35","modified_gmt":"2026-04-30T11:02:35","slug":"bristol-myers-squibb-reports-first-quarter-financial-results-for-2026","status":"publish","type":"post","link":"https:\/\/pharma-trend.com\/en\/bristol-myers-squibb-reports-first-quarter-financial-results-for-2026\/","title":{"rendered":"Bristol Myers Squibb Reports First Quarter Financial Results for 2026"},"content":{"rendered":"
\n

PRINCETON, N.J.–(BUSINESS WIRE)–Bristol Myers Squibb<\/a> (NYSE: BMY) today reported first quarter 2026 financial results.<\/p>\n

<\/a>
<\/a><\/p>\n

\nVisit the company\u2019s Investor Relations website at http:\/\/investor.bms.com<\/a> to view the detailed first quarter 2026 earnings press release<\/a> and investor presentation.<\/p>\n

\nThe company will host a conference call and live audio webcast for analysts and investors at 8:00 a.m. ET today, April 30, 2026, which is accessible here<\/a>. Company executives will review financial results with the investment community during the call.<\/p>\n

\nA replay of the webcast will be available at http:\/\/investor.bms.com<\/a> approximately three hours after the conference call concludes.<\/p>\n

\nAbout Bristol Myers Squibb: Transforming Patients’ Lives Through Science
\n
<\/span><\/b>At Bristol Myers Squibb, our mission is to discover, develop and deliver innovative medicines that help patients prevail over serious diseases. We are pursuing bold science to define what’s possible for the future of medicine and the patients we serve. For more information, visit us at BMS.com<\/a> and follow us on LinkedIn<\/a>, X<\/a>, YouTube<\/a>, Facebook<\/a> and Instagram<\/a>.<\/p>\n

\ncorporatefinancial-news<\/p>\n

Contacts<\/b> <\/p>\n

\nMedia Relations: media@bms.com<\/a><\/p>\n

\nInvestor Relations: investor.relations@bms.com<\/a><\/p>\n<\/div>\n","protected":false},"excerpt":{"rendered":"

PRINCETON, N.J.–(BUSINESS WIRE)–Bristol Myers Squibb (NYSE: BMY) today reported first quarter 2026 financial results. Visit the company\u2019s Investor Relations website at http:\/\/investor.bms.com to view the detailed first quarter 2026 earnings press release and investor presentation. The company will host a conference call and live audio webcast for analysts and investors at 8:00 a.m. ET today, … [Read more…]<\/a><\/span><\/p>\n","protected":false},"author":4,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[13],"tags":[],"class_list":{"0":"entry","1":"post","2":"publish","3":"author-business","4":"post-63031","6":"format-standard","7":"category-industry"},"yoast_head":"\nBristol Myers Squibb Reports First Quarter Financial Results for 2026 - Pharma Trend<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/pharma-trend.com\/en\/bristol-myers-squibb-reports-first-quarter-financial-results-for-2026\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Bristol Myers Squibb Reports First Quarter Financial Results for 2026 - Pharma Trend\" \/>\n<meta property=\"og:description\" content=\"PRINCETON, N.J.–(BUSINESS WIRE)–Bristol Myers Squibb (NYSE: BMY) today reported first quarter 2026 financial results. Visit the company\u2019s Investor Relations website at http:\/\/investor.bms.com to view the detailed first quarter 2026 earnings press release and investor presentation. The company will host a conference call and live audio webcast for analysts and investors at 8:00 a.m. ET today, ... [Read more...]\" \/>\n<meta property=\"og:url\" content=\"https:\/\/pharma-trend.com\/en\/bristol-myers-squibb-reports-first-quarter-financial-results-for-2026\/\" \/>\n<meta property=\"og:site_name\" content=\"Pharma Trend\" \/>\n<meta property=\"article:published_time\" content=\"2026-04-30T11:02:35+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/mms.businesswire.com\/media\/20260430621474\/en\/2041631\/22\/bms_logo_300_rgb_pos.jpg\" \/>\n<meta name=\"author\" content=\"Business Wire\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Business Wire\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"1 minute\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/bristol-myers-squibb-reports-first-quarter-financial-results-for-2026\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/bristol-myers-squibb-reports-first-quarter-financial-results-for-2026\\\/\"},\"author\":{\"name\":\"Business Wire\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/person\\\/02d41342c7a74fa7f0032bb35ef0bb24\"},\"headline\":\"Bristol Myers Squibb Reports First Quarter Financial Results for 2026\",\"datePublished\":\"2026-04-30T11:02:35+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/bristol-myers-squibb-reports-first-quarter-financial-results-for-2026\\\/\"},\"wordCount\":190,\"publisher\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#organization\"},\"image\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/bristol-myers-squibb-reports-first-quarter-financial-results-for-2026\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20260430621474\\\/en\\\/2041631\\\/22\\\/bms_logo_300_rgb_pos.jpg\",\"articleSection\":[\"Industry\"],\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/bristol-myers-squibb-reports-first-quarter-financial-results-for-2026\\\/\",\"url\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/bristol-myers-squibb-reports-first-quarter-financial-results-for-2026\\\/\",\"name\":\"Bristol Myers Squibb Reports First Quarter Financial Results for 2026 - Pharma Trend\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/bristol-myers-squibb-reports-first-quarter-financial-results-for-2026\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/bristol-myers-squibb-reports-first-quarter-financial-results-for-2026\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20260430621474\\\/en\\\/2041631\\\/22\\\/bms_logo_300_rgb_pos.jpg\",\"datePublished\":\"2026-04-30T11:02:35+00:00\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/bristol-myers-squibb-reports-first-quarter-financial-results-for-2026\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/pharma-trend.com\\\/en\\\/bristol-myers-squibb-reports-first-quarter-financial-results-for-2026\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/bristol-myers-squibb-reports-first-quarter-financial-results-for-2026\\\/#primaryimage\",\"url\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20260430621474\\\/en\\\/2041631\\\/22\\\/bms_logo_300_rgb_pos.jpg\",\"contentUrl\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20260430621474\\\/en\\\/2041631\\\/22\\\/bms_logo_300_rgb_pos.jpg\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/bristol-myers-squibb-reports-first-quarter-financial-results-for-2026\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Startseite\",\"item\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Bristol Myers Squibb Reports First Quarter Financial Results for 2026\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#website\",\"url\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/\",\"name\":\"Pharma Trend\",\"description\":\"\",\"publisher\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#organization\",\"name\":\"Pharma Trend\",\"url\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/logo\\\/image\\\/\",\"url\":\"\",\"contentUrl\":\"\",\"caption\":\"Pharma Trend\"},\"image\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/logo\\\/image\\\/\"}},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/person\\\/02d41342c7a74fa7f0032bb35ef0bb24\",\"name\":\"Business Wire\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Bristol Myers Squibb Reports First Quarter Financial Results for 2026 - Pharma Trend","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/pharma-trend.com\/en\/bristol-myers-squibb-reports-first-quarter-financial-results-for-2026\/","og_locale":"en_US","og_type":"article","og_title":"Bristol Myers Squibb Reports First Quarter Financial Results for 2026 - Pharma Trend","og_description":"PRINCETON, N.J.–(BUSINESS WIRE)–Bristol Myers Squibb (NYSE: BMY) today reported first quarter 2026 financial results. Visit the company\u2019s Investor Relations website at http:\/\/investor.bms.com to view the detailed first quarter 2026 earnings press release and investor presentation. The company will host a conference call and live audio webcast for analysts and investors at 8:00 a.m. ET today, ... [Read more...]","og_url":"https:\/\/pharma-trend.com\/en\/bristol-myers-squibb-reports-first-quarter-financial-results-for-2026\/","og_site_name":"Pharma Trend","article_published_time":"2026-04-30T11:02:35+00:00","og_image":[{"url":"https:\/\/mms.businesswire.com\/media\/20260430621474\/en\/2041631\/22\/bms_logo_300_rgb_pos.jpg","type":"","width":"","height":""}],"author":"Business Wire","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Business Wire","Est. reading time":"1 minute"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/pharma-trend.com\/en\/bristol-myers-squibb-reports-first-quarter-financial-results-for-2026\/#article","isPartOf":{"@id":"https:\/\/pharma-trend.com\/en\/bristol-myers-squibb-reports-first-quarter-financial-results-for-2026\/"},"author":{"name":"Business Wire","@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/person\/02d41342c7a74fa7f0032bb35ef0bb24"},"headline":"Bristol Myers Squibb Reports First Quarter Financial Results for 2026","datePublished":"2026-04-30T11:02:35+00:00","mainEntityOfPage":{"@id":"https:\/\/pharma-trend.com\/en\/bristol-myers-squibb-reports-first-quarter-financial-results-for-2026\/"},"wordCount":190,"publisher":{"@id":"https:\/\/pharma-trend.com\/en\/#organization"},"image":{"@id":"https:\/\/pharma-trend.com\/en\/bristol-myers-squibb-reports-first-quarter-financial-results-for-2026\/#primaryimage"},"thumbnailUrl":"https:\/\/mms.businesswire.com\/media\/20260430621474\/en\/2041631\/22\/bms_logo_300_rgb_pos.jpg","articleSection":["Industry"],"inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/pharma-trend.com\/en\/bristol-myers-squibb-reports-first-quarter-financial-results-for-2026\/","url":"https:\/\/pharma-trend.com\/en\/bristol-myers-squibb-reports-first-quarter-financial-results-for-2026\/","name":"Bristol Myers Squibb Reports First Quarter Financial Results for 2026 - Pharma Trend","isPartOf":{"@id":"https:\/\/pharma-trend.com\/en\/#website"},"primaryImageOfPage":{"@id":"https:\/\/pharma-trend.com\/en\/bristol-myers-squibb-reports-first-quarter-financial-results-for-2026\/#primaryimage"},"image":{"@id":"https:\/\/pharma-trend.com\/en\/bristol-myers-squibb-reports-first-quarter-financial-results-for-2026\/#primaryimage"},"thumbnailUrl":"https:\/\/mms.businesswire.com\/media\/20260430621474\/en\/2041631\/22\/bms_logo_300_rgb_pos.jpg","datePublished":"2026-04-30T11:02:35+00:00","breadcrumb":{"@id":"https:\/\/pharma-trend.com\/en\/bristol-myers-squibb-reports-first-quarter-financial-results-for-2026\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/pharma-trend.com\/en\/bristol-myers-squibb-reports-first-quarter-financial-results-for-2026\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/pharma-trend.com\/en\/bristol-myers-squibb-reports-first-quarter-financial-results-for-2026\/#primaryimage","url":"https:\/\/mms.businesswire.com\/media\/20260430621474\/en\/2041631\/22\/bms_logo_300_rgb_pos.jpg","contentUrl":"https:\/\/mms.businesswire.com\/media\/20260430621474\/en\/2041631\/22\/bms_logo_300_rgb_pos.jpg"},{"@type":"BreadcrumbList","@id":"https:\/\/pharma-trend.com\/en\/bristol-myers-squibb-reports-first-quarter-financial-results-for-2026\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Startseite","item":"https:\/\/pharma-trend.com\/en\/"},{"@type":"ListItem","position":2,"name":"Bristol Myers Squibb Reports First Quarter Financial Results for 2026"}]},{"@type":"WebSite","@id":"https:\/\/pharma-trend.com\/en\/#website","url":"https:\/\/pharma-trend.com\/en\/","name":"Pharma Trend","description":"","publisher":{"@id":"https:\/\/pharma-trend.com\/en\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/pharma-trend.com\/en\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Organization","@id":"https:\/\/pharma-trend.com\/en\/#organization","name":"Pharma Trend","url":"https:\/\/pharma-trend.com\/en\/","logo":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/logo\/image\/","url":"","contentUrl":"","caption":"Pharma Trend"},"image":{"@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/logo\/image\/"}},{"@type":"Person","@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/person\/02d41342c7a74fa7f0032bb35ef0bb24","name":"Business Wire"}]}},"_links":{"self":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/posts\/63031","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/users\/4"}],"replies":[{"embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/comments?post=63031"}],"version-history":[{"count":0,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/posts\/63031\/revisions"}],"wp:attachment":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/media?parent=63031"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/categories?post=63031"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/tags?post=63031"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}